164 results
Page 4 of 9
6-K
EX-99.2
4qg6c80nn
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
v5t27yqa 5bq94rml
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
p5wjyvalj6 9b
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
ptu6nubo3u9s
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
isp77r
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.1
qdzlgz67knvqihsgd
30 Nov 20
RepliCel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis
10:05am
6-K
EX-99.2
iz32u
12 Nov 20
RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
10:06am
6-K
EX-99.1
3zkmbpgvve0z6cqly
12 Nov 20
RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
10:06am
6-K
EX-99.2
nfb1768u6t hfz2
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.3
6ml6cqxhlwip i5yr
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm
6-K
EX-99.2
08v2pa 2kxnfezjd
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm
6-K
EX-99.1
5kov2ktqv4my4git7onz
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm
6-K
EX-99.3
5ubve4 4p2rju9fm
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.4
gpg3baq
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.2
8kdqf6ciw1y91zyr97q1
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.2
vzfdk239iu9z4k
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.2
9mdwhun
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.1
o9iwu7vdcrrcwz
23 Dec 19
RepliCel Announces its Incoming Board of Directors
5:21pm